CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study
-
* Corresponding authors: Shan Wang-Gohrke shan.wang@medizin.uni-ulm.de - Jenny Chang-Claude j.chang-claude@dkfz-heidelberg.de
Breast Cancer Research 2005, 7:R455-R464 doi:10.1186/bcr1027
Accesses
- Last 30 days: 46 accesses
- Last year: 449 accesses
- All time: 3252 accesses
Cited by
BioMed Central: 3 citations
|
Research article
Cinzia Antognelli, Chiara Del Buono, Vienna Ludovini, Stefania Gori, Vincenzo N Talesa, Lucio Crinò, Francesco Barberini, Antonio Rulli BMC Cancer 2009, 9:115 (20 April 2009) |
|
Commentary
CYP17 and breast cancer: no overall effect, but what about interactions? Julian Little, Jacques Simard Breast Cancer Research 2005, 7:238-242 (20 September 2005) |
|
Research article
CYP17 gene polymorphism in relation to breast cancer risk: a case-control study Kristjana Einarsdóttir, Tove Rylander-Rudqvist, Keith Humphreys, Susanne Ahlberg, Gudrun Jonasdottir, Elisabete Weiderpass, Kee Chia, Magnus Ingelman-Sundberg, Ingemar Persson, Jianjun Liu, Per Hall, Sara Wedrén Breast Cancer Research 2005, 7:R890-R896 (14 September 2005) |
